80 likes | 88 Views
The Germany IVD Market accounted for $3,727 million in 2016, and is estimated to reach at $5,453 million by 2023, growing at a CAGR of 5.5% from 2017 to 2023.
E N D
Skim Market Met Germany IVD Market Global Opportunity Analysis & Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast 2030 Global Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2017-2023 Global Opportunity Analysis and Industry Forecast 2023 Pages:140 Tables:39 Charts:54
Germany IVD Market “The utilization of IVD techniques is expected to witness a significant rise with increasing diagnosis of diseases. Also, the IVD market has piqued the interest of healthcare industry owing to its high accuracy and precise techniques coupled with its wide range of applications across various disease indications.” HemaliNarkhede Manager, Healthcare Research at AMR
Germany IVD Market Germany IVD Market was valued at $3,727 million in 2016, and is projected to reach at $5,453 million by 2023, growing at a CAGR of 5.5% from 2017 to 2023. The immunodiagnostics segment accounted for more than one-third share of the total market in 2016. In vitro diagnostics plays a vital role in the healthcare sector for early detection, diagnosis, and treatment of various diseases and disorders. Diseases such as infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases are diagnosed in in vitro conditions. Incessant innovations in IVD product design and technological advancement have enabled to perform diagnostic test at home, which have encouraged patients to shift their focus from traditional medical methods to personalized medicines.
Germany IVD Market Constant technological developments to improve efficacy of IVD, increase in geriatric population, rise in incidence and prevalence of infectious and chronic diseases, and increase in outsourcing of laboratories in Germany region drive the market growth. However, unfavorable reimbursement policies and stringent government regulations related to the safety and efficacy of the IVD are expected to restrain the market growth during the forecast period. Ongoing R&D associated with the IVD and increase in awareness of preventive healthcare measures provides huge growth potential for IVD market. Based on product type, the reagents segment held the highest market share in 2016, owing to the recent introduction of new novel reagents in the market that are more effective. Download Request Sample: https://www.alliedmarketresearch.com/request-sample/4138
Germany IVD Market Based on techniques, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of chronic and infectious diseases and rise in awareness of personalized medicine among the population. Based on application, the infectious diseases segment contributed the highest market share in 2016, owing to the increase in prevalence of infectious diseases and rise in awareness of preventive health measures. Based on end user, the standalone laboratory segment captured the highest market share in 2016, mainly due to wide availability of complex tests and high-tech infrastructure enabling fast and accurate test results. Download Request Sample: https://www.alliedmarketresearch.com/request-sample/4138
Germany IVD Market • Major Companies: • ThermoFisher Scientific Inc. • Alere Inc. • Biomerieux • Danaher Corporation • F. Hoffmann-La Roche AG • Becton Dickinson and Company • Bio-Rad Laboratories • Bayer AG • Sysmex Corporation • Johnson & Johnson
Germany IVD Market • Key Findings of the Germany IVD Market: • The reagent segment dominated the market in 2016, and is projected to grow at the highest CAGR. • The immunodiagnostics segment accounted for the highest share of one-third of total in 2016. • The infectious diseases segment was the major shareholder in the Germany IVD based application market in 2016. • The standalone laboratory segment accounted for the highest share of in 2016. • Send Enquiry on Report: https://www.alliedmarketresearch.com/purchase-enquiry/4138
Germany IVD Market • Contact: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • Toll Free (USA/Canada): • +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060 • Fax: +1⟨855⟩550-5975 • help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com